drugset / Trial / NCT05325190

Granisetron Transdermal Patch System for Prevention of CINV by CapeOX

NCT05325190

NaSingle-groupOpen-labelPrevention

Summary

This study aims to explore the prevention of delayed chemotherapy induced by CAPOX regimen with granisetron transdermal patch。

Timeline

Start
2021-10-10
Primary completion
2022-12-30
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified 3.1 mg Other